Top

Published in:

01-01-2003

MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall Survival

Authors: Lydia Nakopoulou, Ioanna Tsirmpa, Paraskevi Alexandrou, Androniki Louvrou, Constantine Ampela, Sophia Markaki, Panayiotis S. Davaris

Published in: Breast Cancer Research and Treatment | Issue 2/2003

Title: MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall Survival
Authors: Lydia Nakopoulou
Ioanna Tsirmpa
Paraskevi Alexandrou
Androniki Louvrou
Constantine Ampela
Sophia Markaki
Panayiotis S. Davaris
Publication date: 01-01-2003
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 2/2003
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/A:1021371028777

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2003

Phytoestrogens and Breast Cancer Risk

Instructions for Authors

Unexpected Low Efficacy of Stealth Liposomal Doxorubicin (Caelyx) and Vinorelbine in Metastatic Breast Cancer

Simple Anesthesia for Simple Mastectomies

Chromosome 17 Aneusomy is Associated with Poor Prognostic Factors in Invasive Breast Carcinoma

Cytotoxic Effect of Conjugates of Doxorubicin and Human Chorionic Gonadotropin (hCG) in Breast Cancer Cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer